Myanmar FDA registration 8945d0b4e28068029aef3ab0e1521c21
XIENCE Xpedition Everolimus Eluting Coronary Stent System
Myanmar·Abbott·Abbott Vascular·Registered September 07, 2022Device classification
- Brand Name
- Abbott
Registration information
- Analysis ID
- 8945d0b4e28068029aef3ab0e1521c21
- Registration Date
- September 07, 2022
Manufacturer
- Name
- Abbott Vascular
Authorized Representative
About this record
Access comprehensive regulatory information for XIENCE Xpedition Everolimus Eluting Coronary Stent System in the Myanmar medical device market through Pure Global AI's free database. This medical device is registered under FDA ID 8945d0b4e28068029aef3ab0e1521c21 and manufactured by Abbott Vascular. The device was registered on September 07, 2022.
This page provides complete registration details including manufacturer information, authorized representative details, and regulatory compliance data from the official Myanmar FDA medical device database. Pure Global AI offers free access to Myanmar's complete medical device registry.
Free DatabasePowered by Pure Global AIFDA Official Data